* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
None
What’s baking in the oven?
It's a little empty
Banquet Buffet****
African Pioneer 1.825p £9.6m (AFP.L)
The exploration and resource development company with projects in Namibia, Zambia and Botswana, announced that further to its announcement on 12 June 2026 it has signed a conditional definitive financing and technical services agreement with Hong Kong Xinhai Mining Services Limited, a globally recognised engineering, procurement, construction and mine development group in relation to African Pioneer's Ongombo and Ongeama projects. The Definitive Agreement, on substantively the terms in the heads of agreement previously announced, is for the development and financing of the Ongombo and Ongeama copper projects in Namibia. It establishes a project holding company to hold a 95% interest in the Namibian Projects, sets out loan facilities to be provided by Xinhai to the Holding Company to finance the agreed development milestones, and covers debt-to-equity conversion, governance, confidentiality, dispute resolution, and other operational and legal provisions. Xinhai shall subscribe GBP712,786 at 1.15p for a 10% interest in the enlarged share capital of African Pioneer.
Foxtons Group 39.95p £118.1m (FOXT.L)
The estate and letting agency brand reported interim results for the half year ended 30 June 2026. The company reported a challenging H1 market backdrop reflecting materially lower volumes in the sales market and short-term volatility in the lettings market following the introduction of the Renters' Rights Act. While market conditions weighed on performance, the Group's strategic focus on growing Lettings has created a more resilient business with a stronger recurring revenue profile. The group reported revenue down 3% to £83.7m, with lettings revenue flat, as growth in Build to Rent and ancillary services (plus a £1.7m acquisition contribution) was offset by a £3m reversal of previously recognised revenue from tenant-led terminations. Sales revenue dropped 13% against a strong comparator period, while financial services revenue rose 20% on stronger refinancing volumes and operational upgrades. Non-cyclical and recurring revenues generated 69% of the total revenue in H1 2026.
Halo Minerals 9.875p £10.9m (HALO.L)
The copper development company focused on extracting critical minerals from legacy mining waste, announced that the First Environmental Tribunal of Chile has rejected in its entirety the judicial challenge filed on 28 November 2025 against the Chilean Committee of Ministers' environmental approval of the Company's Playa Verde project, which was received in written resolution on 15 October 2025. On the operational side, the Company continues to make good progress across a number of key technical and permitting workstreams at Playa Verde. In conjunction with BIOS Mining & Infrastructure, the Company is advancing the optimisation programme and refinement of project economics, with a particular focus on updating CAPEX and OPEX estimates to BFS-standard.
Mycelx Technologies Corp 56p £13.5m (MYX.L)
The provider of proprietary water treatment technology to the Oil and Gas and other industries worldwide, provides a trading update for the interims to June. Revenue increased $2.1m from $1.7m primarily from paid trials, leases and recurring media sales. There is $3.9m of revenue expected to be recognised in Q3 2026 relating to the delivery of a REGEN system for the produced water treatment project award in the Permian Basin. The cash at 30 June 2026 was around $500,000 with a further $1.1m of customer payments received in July following period end. MYCELX enters the second half of 2026 with increased commercial momentum and is on track to meet the market's expectations for FY2026 of $11.0m revenue with 80% of that amount either already booked, contracted or expected through recurring lease and media sales.
Ondine Biomedical 14p £72.7m (OBI.L)
The company focused on light-activated antimicrobial therapies to prevent and treat hospital infections, together with its UK distribution partner, Molnlycke Health Care, announced that NHS Golden Jubilee is the first hospital in Scotland to adopt Steriwave nasal photodisinfection. The milestone brings Steriwave into the surgical pathway at the UK's largest hip and knee replacement centre, supporting the hospital's commitment to advancing the Scottish Government's 2026 health objectives and reinforcing the role of rapid, non-antibiotic infection prevention in protecting surgical capacity and supporting high-quality patient care. NHS Golden Jubilee performs approximately 30% of Scotland's hip and knee replacements and plays a central role in delivering elective orthopaedic care for patients across the country.
PCI-PAL 51p £37m (PCIP.L)
The global cloud provider of secure payment solutions for business communications, announced that its new strategic integrated reseller partnership is with NiCE, a global provider of customer experience, AI and business communications technology. The partnership sees PCI Pal recognised as a Strategic DEVone Partner within the NiCE CXexchange marketplace. Through the partnership, NiCE customers can seamlessly incorporate compliant and secure payments natively within the NiCE CXone platform across voice and digital channels, supporting both live-agent and AI-powered customer interactions through a single, consistent payment experience.
Ten Lifestyle Group 94p £90.9m (TENG.L)
The global customer experience and loyalty platform for premium brands today announces a new partnership spanning a selection of AEG Presents' UK venues, festivals and live entertainment events. Under the agreement, Ten becomes an official partner across key AEG Presents venues and events, including Indigo at The O2, Watford Colosseum, University of Wolverhampton at The Halls and the iconic C2C: Country to Country festival. The partnership will provide eligible Ten members with enhanced access to a curated range of high-demand events and tours, with tickets made available through Ten's closed-user member ecosystem. Ticket inventory will be distributed via Ten Box Office, Ten's proprietary ticketing platform, which enables eligible members to discover and book a curated programme of premium live entertainment, including theatre, music, family shows and sporting events.
Watkin Jones 18.2p £46.8m (WJG.L)
The UK developer and manager of residential for rent, updated on trading for the three months to 30 June 2026. Whilst the geopolitical and economic backdrop continues to impact both confidence and liquidity in key markets, the Group remains focused on execution and the factors within its control. The company has signed six new contracts with a combined value of approximately £60m in the second half to date. These include five new contracts secured by the Refresh division, the Group's refurbishment and asset improvement platform, and a partnership with Marick Real Estate to develop a Staycity aparthotel scheme in Oxford's city centre. The Refresh schemes relate to existing Purpose Built Student Accommodation assets where the Group will deliver remediation, fire safety, refurbishment and asset improvement works further highlighting the growing demand from investors seeking to modernise, enhance, and future-proof existing residential assets whilst enhancing sustainability with lowered operating costs.
Zoo Digital Group 9.75p £9.6m (ZOO.L)
The tech-enabled localisation and digital media services partner to the global media and entertainment industry reports Finals for the FY 31 March 2026. Revenue is 14.7% lower at $42.3m with an operating loss of $1.6m compared to a $6.5m loss in 2025 and a LBT of $2.3m which is 72% lower than last year. The cash EBITDA was positive at $0.4m against a negative $2.7m with gross cash 18.5% ahead of last year’s $3.3m. The company reported a transformational year with the restructuring programme completed, improved profitability and strengthened cash generation.
AQSE Market:
Ormonde Mining 0.25p £1.2m (AQSE:ORM) The natural resources company with investment exposure to gold and battery metal exploration assets in Newfoundland, Spain and Scotland, notes the recent update by Winshear Metals Corp., regarding successful metallurgical testwork conducted on the nickel-copper-cobalt mineralisation at the Rodburn Target, part of the Portsoy Project in Aberdeenshire, Scotland. The Rodburn Target is owned by Peak Nickel Limited, in which Ormonde holds an 18.9% equity interest, and is being advanced under an option agreement with Winshear, which is fully funding exploration at the project. The objective was to determine the amenability of the mineralisation to respond to conventional sequential flotation methods and produce marketable copper and nickel concentrates. Head assays were 0.82% copper, 1.64% nickel (1.38% nickel in sulphide), and 0.11% cobalt. Based on the batch tests, copper recoveries of 75-80% and nickel of 60-65% can be expected.
What’s baking in the oven?
Potential IPOs:***
Dual List:***
18th February: Amaroq Ltd (AMRQ.L), the AIM quoted independent mine development company focused on unlocking Greenland’s mineral potential, announced its intention to move to the Main Market. The CEO believes a move to the Main Market will enhance the company’s visibility in the capital markets and support access to a broader pool of institutional capital. Admission is expected to occur no earlier than 31 July 2026.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
